Formula Swiss Logo.png
Formula Swiss Announces Expansion into Sweden and Finland with New Online Stores
June 21, 2024 09:00 ET | Formula Swiss
Zug, Switzerland, June 21, 2024 (GLOBE NEWSWIRE) -- Formula Swiss, a market leader for certified CBD products in Europe and the only CBD company investing in animal research, is excited to announce...
22157.jpg
The Future of Cannabidiol (CBD) Pain Treatments, 2024: Commercial and Clinical Assessment with Analysis of Pipeline Development Activities
May 28, 2024 07:19 ET | Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Cannabidiol (CBD) Pain - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The medical and pharmaceutical...
Global E-Cigarettes Market
e-Cigarettes Market Opportunities and Strategies to 2033: A $66.5 Billion Opportunity Dominated by Philip Morris Int'l, Altria Group, JUUL Labs, British American Tobacco, Japan Tobacco
May 17, 2024 10:20 ET | Research and Markets
Dublin, May 17, 2024 (GLOBE NEWSWIRE) -- The "E-Cigarettes Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.The global e-cigarettes...
brains.jpg
Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division
May 06, 2024 06:00 ET | Brains Bioceutical Corp
VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health...
Global Epilepsy Drugs Market
Epilepsy Drugs Market Report and Global Forecast 2024-2030, Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health Companies, GSK, Novartis and Pfizer
May 06, 2024 04:04 ET | Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis" report has...
scilogo.jpg
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
March 21, 2024 08:58 ET | SciSparc Ltd
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC)...
CANB.png
Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million
March 11, 2024 08:15 ET | Can B Corp
The Patents Term – Presumed Valid By Law – Extends to 2035 HICKSVILLE, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp., a Florida corporation (OTCQB: CANB) (“Can B”), a...
Vantage Facilities (1)
Vantage Hemp Co. Achieves GMP Certification from Australia's Therapeutic Goods Administration
February 29, 2024 07:00 ET | Vantage Hemp Co.
Greeley, Colorado, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or “the Company”), a globally accredited plant-based extractor and finished product manufacturer, is proud to...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Cannabidiol Market Soars to USD 36.6 Billion by 2033 || Growing Demand For Personal Care Products
December 11, 2023 02:52 ET | Market.Us
New York, Dec. 11, 2023 (GLOBE NEWSWIRE) -- According to the market.us, the global Cannabidiol Market Size was valued at USD 7.6 billion in 2023 and is anticipated to reach approximately USD 36.6...
scilogo.jpg
New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder
November 24, 2023 08:55 ET | SciSparc Ltd
TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...